Evidence map›Paper›PMID 42121060›Full record

Trial reportBMC cardiovascular disorders2026

Sedentary behavior with atrial fibrillation-related biomarkers in overweight or obese adults.

Linzi Li, Amit Shah, Yi-An Ko, Dayna A Johnson, Dora Romaguera, Angel M Alonso-Gómez, Estefanía Toledo, Cristina Razquin, Jadwiga Konieczna, Miguel Angel Martinez-Gonzalez and 3 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Linzi LiDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, United States. linzi.li@emory.edu.
Amit ShahDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, United States.
Yi-An KoDepartment of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, United States.
Dayna A JohnsonDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, United States.
Dora RomagueraCentro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Angel M Alonso-GómezCentro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Estefanía ToledoCentro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Cristina RazquinCentro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Jadwiga KoniecznaCentro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Miguel Angel Martinez-GonzalezCentro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Julia WarnbergCentro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Montserrat FitóCentro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Alvaro AlonsoDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, United States.

Funding

Effect of an Intensive Lifestyle Intervention on the Atrial Fibrillation SubstrateR01HL137338 · NHLBI · EMORY UNIVERSITY · PI ALONSO, ALVARO · 2018 to 2021
$2.8M
American Heart Association 23PRE1020888NHLBI NIH HHS R01HL137338
6 · The paper itself

Abstract

backgroundBlood biomarkers can characterize the atrial substrate and help elucidate mechanisms of atrial fibrillation (AF) development. Understanding whether sedentary behavior affects AF-related biomarkers may inform prevention strategies.

methodsWe studied 252 participants in PREDIMED-Plus, a multicenter randomized trial in Spain for the primary prevention of cardiovascular disease. Participants wore wrist accelerometers for one week at baseline and at least once during follow-up (years 3 or 5). Blood samples were collected at each time point to measure selected biomarkers: propeptide of procollagen type I, high-sensitivity (hs) troponin T (hsTnT), hs C-reactive protein, 3-nitrotyrosine, and N-terminal propeptide of B-type natriuretic peptide (NT-proBNP). Using isotemporal substitution, we estimated the effect of replacing 30 min/day of sedentary time (< 1.5 METs in waking time) with low-intensity physical activity (LPA, 1.5-3 METs), moderate-to-vigorous PA (MVPA, > 3 METs), or time in bed (bedtime to wake-up) on log-transformed biomarker levels, cross-sectionally and longitudinally, via linear regression and mixed models.

resultsAt baseline, participants (mean age 65 ± 4.9 years, BMI 32.2 ± 3.3 kg/m², 40% women) showed no significant cross-sectional associations between substituting sedentary time and biomarker levels. After 5 years, replacing baseline 30-min of sedentary time per day with LPA or MVPA was associated with lower hs-TnT concentrations compared to baseline (-4%, 95% CI -8%, -1%; and - 2%, 95% CI -7%, 4%). Substitutions showed nonsignificant reductions in NT-proBNP but no consistent associations with other biomarkers.

conclusionsAmong overweight/obese individuals, replacing sedentary time with PA was associated with favorable 5-year changes of hs-TnT, but not other AF-related biomarkers.

trial registrationThe trial was registered on July 24, 2014, at ISRCTN (ISRCTN89898870) [ www.isrctn.com/ISRCTN89898870 (accessed on December 10, 2025)].

Indexed as

Atrial FibrillationObesityOverweightSedentary BehaviorActigraphyAgedBiomarkersCross-Sectional StudiesExerciseFemaleHumansMaleMiddle AgedNatriuretic Peptide, BrainPeptide FragmentsPrimary PreventionBiomarkersNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)Troponin TAtrial fibrillationBiomarkersIsotemporal substitutionPhysical activitySedentary behavior

Identifiers

PMID42121060
PMCPMC13339407

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.